USNA - Usana Health Sciences Inc
Close
40.82
0.180 0.441%
Share volume: 63,008
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Toilet Preparation Manufacturing:
3.04%
PREVIOUS CLOSE
CHG
CHG%
$40.64
0.18
0.44%
View ratios
| Fiscal Date | 2022-07-02 | 2022-10-01 | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-30 | 2024-03-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-02-27 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 557.959 M | 556.063 M | 596.549 M | 605.533 M | 602.680 M | 601.148 M | 632.757 M | 629.275 M | |
| Current Assets | 342.004 M | 341.154 M | 384.382 M | 395.878 M | 387.646 M | 390.460 M | 417.746 M | 421.070 M | |
| Inventories | 84.164 M | 67.278 M | 67.089 M | 64.490 M | 61.962 M | 60.081 M | 61.454 M | 60.870 M | |
| Other Current Assets | 27.470 M | 26.997 M | 21.660 M | 35.934 M | 25.501 M | 23.298 M | 18.671 M | 31.864 M | |
| Short Term Investments | 27.470 M | 26.997 M | 21.660 M | 35.934 M | 25.501 M | 23.298 M | 18.671 M | 31.864 M | |
| Total Receivables | 0.000 | 0.000 | 7.213 M | 0.000 | 0.000 | 0.000 | 7.201 M | 0.000 | |
| Current Cash | 230.370 M | 246.879 M | 288.420 M | 295.454 M | 300.183 M | 307.081 M | 330.420 M | 328.336 M | |
| Total Non-current Assets | 215.955 M | 214.909 M | 212.167 M | 209.655 M | 215.034 M | 210.688 M | 215.011 M | 208.205 M | |
| Property Plant Equipment | 97.827 M | 95.228 M | 97.773 M | 96.798 M | 95.736 M | 95.159 M | 99.814 M | 98.186 M | |
| Other Assets | 35.016 M | 37.400 M | 54.795 M | 35.607 M | 36.528 M | 34.131 M | 54.892 M | 32.665 M | |
| Intangible Assets | 34.371 M | 32.158 M | 32.432 M | 31.971 M | 29.997 M | 29.462 M | 29.919 M | 29.105 M | |
| Goodwill | 17.476 M | 17.104 M | 17.368 M | 17.411 M | 16.859 M | 16.801 M | 17.102 M | 16.902 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 557.959 M | 556.063 M | 596.549 M | 605.533 M | 602.680 M | 601.148 M | 632.757 M | 629.275 M | |
| Total liabilities | 154.278 M | 144.964 M | 162.077 M | 150.179 M | 133.856 M | 130.754 M | 135.555 M | 129.287 M | |
| Total current liabilities | 133.594 M | 125.846 M | 143.833 M | 130.222 M | 113.839 M | 112.559 M | 118.845 M | 112.631 M | |
| Accounts Payable | 10.175 M | 10.362 M | 11.049 M | 10.511 M | 9.273 M | 9.321 M | 10.070 M | 8.266 M | |
| Other liabilities | 15.542 M | 14.317 M | 14.173 M | 14.382 M | 15.221 M | 13.448 M | 12.158 M | 11.543 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 786.000 K | 1.320 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 15.542 M | 14.317 M | 14.173 M | 14.382 M | 15.221 M | 13.448 M | 12.158 M | 11.543 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 403.681 M | 411.099 M | 434.472 M | 455.354 M | 468.824 M | 470.394 M | 497.202 M | 499.988 M | |
| Common stock | 19.215 M | 19.221 M | 19.229 M | 19.283 M | 19.321 M | 19.245 M | 19.151 M | 19.174 M | |
| Retained earnings | 363.912 M | 378.841 M | 391.636 M | 410.019 M | 427.311 M | 428.447 M | 445.217 M | 453.451 M |